The article Microdose Announces Ninnion Therapeutics as Wonderland 2022 Platinum Sponsor was originally published on Microdose. The leader in the business...
The founder of two leading psychedelic science companies and an influential nonprofit is shaping research, as well as efforts to patent it. The post...
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics®”, today announced the...
The church, called The Flower of the Divine Mother, offers a glimpse of what religious use of psychedelics could look like in the future. The post...
Silo Wellness Inc. (CSE: SILO | OTCQB: SILFF | FSE: 3K7A), announced that its wholly-owned subsidiary SW Holdings, Inc.’s (“SWHI”) License Agreement...
Eleusis’ IV form of psilocin will see clinical trials, but Eleusis-backed research into the anti-inflammatory properties of psychedelics is uncertain....
The article Microdose Announces MindBio Therapeutics as Wonderland 2022 Platinum Sponsor was originally published on Microdose. The leader in the business...
Source: Clive Maund 10/25/2022 Algernon Pharmaceuticals has entered into a clinical trial agreement with Yale and caught expert Clive Maund's...
Wellbeing Digital Sciences Inc. (NEO: MEDI | OTC: KONEF | (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation...